Does Compound Semaglutide Expire? Shelf Life & Storage

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, compound semaglutide does expire. Most compounded formulations remain stable for 30 days after dispensing when stored at 2-8°C (36-46°F), though expiration dates vary by pharmacy and formulation. Understanding stability windows is essential for treatment efficacy and safety.

Compounded medications require closer attention to storage and expiration than many patients realize. Unlike mass-manufactured drugs with extended shelf lives, 503A compounded semaglutide is prepared specifically for individual patients, making proper refrigeration and expiration awareness critical components of responsible treatment management.

Stability Data and Compounding Pharmacy Standards

Compounded semaglutide stability depends on formulation type, vehicle ingredients, and storage conditions. Licensed 503A compounding pharmacies must follow USP <797> standards, which establish beyond-use dates (BUDs) based on pharmaceutical principles. Most compounded semaglutide injections carry a 30-day BUD when refrigerated.

A study in the Journal of Pharmacy Practice found that peptide-based compounds lose potency faster at room temperature. Maintaining strict cold-chain management from pharmacy dispensing through patient storage directly impacts the medication's bioavailability and clinical efficacy over the treatment month.

Storage Requirements and Practical Handling Guidelines

Proper storage is non-negotiable for compounded semaglutide integrity. All compounded formulations should remain refrigerated at 2-8°C. Never freeze, use after expiration, or leave unrefrigerated for more than 2 hours. Transport in a cooler with ice packs if traveling.

Check expiration dates before each injection. Discard any medication that appears cloudy, discolored, or has visible particles. Keep detailed records of when your compounded medication was dispensed and plan refills accordingly to avoid gaps in your treatment protocol.

Storage Factor	Requirement
Temperature Range	2-8°C (36-46°F) — refrigerate, do not freeze
Beyond-Use Date	Typically 30 days from dispensing by licensed pharmacy
Light Exposure	Store in original container away from direct sunlight
Transport Time	Do not leave unrefrigerated for more than 2 hours
Inspection Before Use	Check for clarity, color, and particulates at each dose
Record Keeping	Document dispensing date and plan refills accordingly

Why Compounded Medications Have Shorter Shelf Lives Than Branded Alternatives

Branded semaglutide (Ozempic, Wegovy) undergoes rigorous stability testing and contains preservatives enabling longer shelf lives. Compounded semaglutide is prepared fresh in smaller batches with minimal or no preservatives, reflecting USP <797> standards that prioritize sterility and patient-specific dosing over extended stability.

This shorter window reflects the compounding advantage: medications are customized to individual needs rather than mass-manufactured. While branded drugs may remain stable for 18-24 months, compounded formulations prioritize freshness and minimize additives, which is medically appropriate for personalized treatment protocols.

Expiration Awareness and Provider Oversight in Your Treatment Plan

Your prescribing provider should outline refill timing alongside your compounded semaglutide protocol. Regular check-ins ensure medication is stored properly, used before expiration, and delivering expected clinical response. Report any concerns about medication appearance or efficacy immediately.

Genetic and biomarker insights—such as those from PlexusDx's Precision Peptide Genetic Test—complement medication storage vigilance by revealing your biological predispositions in GLP-1 pathways. This context helps providers optimize dosing, refill schedules, and overall protocol to maximize therapeutic benefit within stability windows.

How PlexusDx Supports a More Personalized Approach

PlexusDx's approach to compounded medication management integrates biomarker and genetic context with practical safety protocols. Understanding your genetic predispositions in GLP-1 receptor and related peptide pathways may help provide context for how consistently you'll need to maintain your treatment schedule and monitor medication stability.

The Precision Peptide Genetic Test reveals variants in key pathways (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may influence your medication response and optimal dosing protocol. These predispositions should be interpreted with a qualified healthcare provider to align with your compounded medication's beyond-use date and refill requirements.

Combining proper storage discipline with genetic insights supports a more personalized conversation with your provider about dosing adjustments, refill timing, and sustained efficacy. This dual approach—biomarker awareness plus medication vigilance—reinforces the precision-wellness framework that ensures your compounded semaglutide remains safe and therapeutically relevant throughout treatment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.